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We report two patients who presented with dyspnoea, lethargy and weight loss. In both cases
chest radiographs and computed tomography (CT) scans of the thorax were suggestive of bron-
chogenic carcinoma. However, thoracic actinomycosis was confirmed in both cases based on
findings of the surgical biopsy and cultures from chest wall wound. The patients were success-
fully treated with penicillin. Thoracic actinomycosis is a very rare condition, which can pose
a diagnostic challenge. These cases highlight the importance of considering the possibility of
rare infections such as actinomycosis in apparently malignant looking lung lesions. Moreover
this report emphasizes the importance of promptly diagnosing this highly treatable disease
with excellent prognosis.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Actinomycosis is a granulomatous infection of the
cervicofacial, thoracic, abdomino pelvic area and mixed
organs including skin, brain, pericardiumandextremities.Over
the last three decades, the incidence of actinomycosis has
declinedmarkedly.1 Thoracic actinomycosis has been reported44 7739104897; fax: þ44
doctors.org.uk (A. Fahim),
), j.a.kastelik@hull.ac.uk
.uk (A. Campbell), damian.
ll rights reserved.more frequently inpatientswithunderlying lungdisorders such
as bronchiectasis or emphysema as well as on the background
of chronic alcohol abuse.2 It remains a diagnostic challenge as
clinically it may be difficult to distinguish from more common
conditions such as lung neoplasm and pulmonary tuberculosis.
We report two cases of thoracic actinomycosis with different
modes of presentation. Written consent has been obtained
from both patients presented in the case series.
Case 1
A 51-year-old previously fit male presented with a 3-week
history of hemoptysis, left sided chest pain, weight loss and
exertional dyspnoea. Hewas a taxi driver with a 30-pack year
48 A. Fahim et al.history of smoking. Examination was unremarkable without
any evidence of pyrexia, clubbing or lymphadenopathy. The
chest radiograph (Fig. 1a) showed shadowing in the right
upper and left lower zones. A computed tomography (CT)
scan of the thorax (Fig. 1b) revealed a parenchymal opacity
with spiculated margins in the right upper lobe and a cavi-
tating lesion in the left lower lobe (Fig. 1c). A percutaneousFigure 1 a. Chest radiograph with right upper lobe and left lo
computed tomography. c. Left lower lobe cavitating lesion on CT sc
case 1. e. Erythema on anterior chest wall suggesting extension to
suspicion of extension of actinomycosis.CT scan guided biopsy of the left lower lobe lesion was non-
diagnostic. Therefore, a video-assisted thoracoscopic (VATS)
biopsy of left lower lobe was performed. The histology
(Fig. 1d) showed areas of patchy inflammationwith formation
of small abscesses containing ‘sulphur granules’; round or
oval basophilic masses with radiating arrangement of eosin-
ophilic clubs on the surface, a pathological finding suggestivewer lobe opacities. b. Right upper lobe spiculated lesion on
an. d. Histology from left lower lobe showing sulphur granule in
soft tissue. f. Ultrasound of chest wall confirming the clinical
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confirmed on gram stain,which revealed slender, beaded and
weakly gram-positive filamentous bacteria. The patient was
commenced on high dose intravenous benzylpenicillin.
Subsequently he developed erythema and swelling inferior to
his left breast (Fig. 1e). The thoracic ultrasound (Fig. 1f)
showed area of swollen tissue (2 cm 1.5 cm) inferior to
pectoralismajor indenting the chest wall. A repeat CTscan of
the thorax confirmed extension of actinomycosis to the chest
wall. The patient continued to receive high dose of benzyl-
penicillin. His condition gradually improved over a period of 4
weekswhen antibioticswere changed to oral amoxicillin. The
patient is currently well.
Case 2
A 68-year-old male with a background of hypertension pre-
sented with history of dyspnoea, anorexia, weight loss and
lethargy for 4 months. Examination was suggestive of left
sided pleural effusion and an ulcerated left anterior chest
wall mass with extruding green pus. He was pyrexial and
initial blood tests demonstrated raised white cell count of
13.8 (predominantly neutrophilia) and C reactive protein
(CRP) of 62. The chest radiograph on admission revealed
large left sided pleural effusion (Fig. 2a). Pleural fluid
analysis showedacute inflammatory cells only. CTscan of the
thorax (Fig. 2b) revealed large anterior pleurally based mass
in the left lung invading the anterior chest wall with
retrosternal extension. There was a moderate left pleural
effusion, small pericardial effusion and mediastinal lymph-
adenopathy associated with the mass. He had a diagnostic
pleural aspiration, pleural fluid culture and sensitivity and
fine needle aspiration (FNA) from the chestwallwoundwhich
proved negative for malignant cells and organisms.
A percutaneous CT guided biopsy of the mass was not
conclusive so he underwent a repeat CT guided biopsy
(Fig. 2c) of the mass which revealed non-specific inflamma-
tory changes without evidence of neoplasia. Subsequently
swabs from the chest wall woundwere specifically examined
for actinomycosis and nocardia in view of repeatedly nega-
tivebiopsies.Ultimately a growthofActinomyces israeliiwas
confirmed on these swabs. The patient was commenced on
high dose intravenous benzylpenicillin. His symptoms grad-
ually improved and antibiotics were changed to oral amoxi-
cillin. The drainage of pus from the chestwall ceased and the
induration reduced significantly. The repeat CTscan (Fig. 2d)
after 3 months showed reduction in the size of the mass and
effusion. The patient is currently well.
Discussion
The most common form, the cervicofacial actinomycosis, is
reported in 50e60%of cases. The secondmost common formof
presentation is thoracic actinomycosis, which has been
reported in 15e20% of cases. Actinomyces species are higher
prokaryotic bacteria belonging to the family Actino-
myceataceae.3A. israelii, the main species responsible for
human disease, was first isolated in 1891.4 These are filamen-
tous, gram-positive, anaerobic-to-microaerophilic bacteria
that are not acid fast. The usual mechanism of infection is by
aspiration of oropharyngeal secretions although occasionally,it may result from the introduction of organisms via oesopha-
geal perforation or haematogenous spread from a distant
lesion. Moreover adult males with poor dental hygiene appear
to be at greatest risk to develop actinomycosis and it was evi-
denced in one of the two patients described in this report.
As evidenced by the two cases described, the clinical
presentation of thoracic actinomycosis may vary. Thoracic
actinomycosis usually presents with dyspnoea, cough,
which may either be dry or productive, hemoptysis and
chest pain. These symptoms were reported in our first
patient. Clinical examination may reveal sinus tract on the
chest wall as evidenced in our second case. Computed
tomography on its own is not diagnostic but may help in
evaluating the exact location and the extent of disease and
to help direct accurate biopsy as well as assist in monitoring
the response to treatment. The non-specific clinical and
laboratory findings in actinomycosis add to the difficulty in
diagnosing this disease. Moreover the mode of presentation
can vary substantially between patients. In a case series of
22 patients5 with actinomycosis the most common radio-
graphic findings were unilateral areas of airspace consoli-
dation. In contrast, in our first patient the chest radiograph
and thoracic CT scan revealed bilateral lesions including
a cavitating lesion in the left lower lobe highly suspicious of
primary bronchogenic carcinoma.
To confirm thoracic actinomycosis a sample from the
lung biopsy is usually required. Fiberoptic bronchoscopy is
not usually diagnostic unless there is a visible endobronchial
disease amenable to endobronchial biopsy.6 Endobronchial
actinomycosis may have a number of manifestations. For
example, it can present as an irregular granular thickening,
which can mimic a sub-mucosal tumour or as a florid
disease in the form of exophytic masses and purulent
exudates. A CT or ultrasound guided biopsy is usually
recommended prior to the surgical biopsy. However, as it
was reported in our both patients, the CT guided biopsies
may not be diagnostic. Thus, the gold standard for
diagnosis of thoracic actinomycosis is a histological
confirmation on lung biopsy, as in case 1. However, in
some patients, as described in our case 2, a less invasive
approach through the analysis of pus from a chest wall
ulcer may be sufficient to reveal the growth of A.
israelii.
Sulfonamides were first breakthrough therapy in acti-
nomycosis in the late 1930s. However, since 1950s penicillin
has remained the drug of choice.7 The rationale for the use
of penicillin is based on the successful clinical experience
rather than randomised controlled trials.1 Thoracic acti-
nomycosis generally requires longer treatment with anti-
biotics compared with the other forms.8 The treatment of
thoracic actinomycosis requires high dose intravenous
benzylpenicillin for 4e6 weeks followed by oral penicillin
for a further 6e12 months depending on response.
However, in a retrospective case series JaeChol Choi and
colleagues9 demonstrated that if surgical resection is per-
formed a shorter course of intravenous antibiotics can be
considered. Kinnear and MacFarlane10 described 19
patients in whom thoracic actinomycosis was completely
resolved with a median of 6 (range 1e24) weeks duration of
antibiotic therapy including 7 patients diagnosed with
actinomycosis following surgical resection. Tetracycline is
an alternative form of therapy in penicillin allergic
Figure 2 a. Left pleural effusion on initial radiograph in case 2. b. CT thorax showing left pleural effusion and large anterior
pleural based mass lesion extending from chest wall to mediastinum. c. Histology from CT guided biopsy of the mass showing non
specific chronic inflammation without evidence of malignancy. d. Repeat CT scan after treatment with penicillin suggestive of
marked radiological improvement.
50 A. Fahim et al.patients. Surgery is an important adjunct to treatment if
there are complications such as well-defined abscesses and
empyema, or if there is life threatening hemoptysis, which
is a very rare complication of thoracic actinomycosis.
The thoracic actinomycosis can pose a diagnostic chal-
lenge. The two described cases highlighted the diversity of
presentation as well as providing an opportunity for
increasing the clinicians’ awareness of this rare condition.
Thoracic actinomycosis can mimic other more common
conditions such as pulmonary neoplasm, tuberculosis or lung
abscess. In fact, in our described cases the radiological
findings were suggestive of bronchogenic carcinoma with
cavitation, pleural adenocarcinoma or lymphoma with
mediastinal lymphadenopathy and bony invasion. Case 2 also
highlighted the importance of considering a diagnosis of
actinomycosis when there is a direct chest wall invasion
associated with pleural effusion. In conclusion, thoracic
actinomycosis is a rare but important clinical disease with
excellent prognosis if treated promptly. Therefore, respira-
tory physicians should consider thoracic actinomycosis in the
differential diagnosis of persistent pulmonary shadowing.
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